key: cord-0956223-4dwoshc2
authors: Habib, Mhd Baraa; Mohammad Obeidat, Ibrahim; Ali, Khaled; Abdelrazek, Mohamed; Mohamed, Mouhand F. H.
title: Bronchopleural fistula causing persistent pneumothorax in COVID‐19 pneumonia patient with no risk factors
date: 2021-11-19
journal: Clin Case Rep
DOI: 10.1002/ccr3.5128
sha: 1eccb67f3dc4d7b25034bd425fc938eb4fa6c186
doc_id: 956223
cord_uid: 4dwoshc2

Although pneumothorax is a well‐known complication of COVID‐19 pneumonia especially in patients requiring mechanical ventilation, bronchopleural fistula causing persistent pneumothorax in sole COVID‐19 pneumonia is extremely rare. In this case, we illustrate that bronchopleural fistula can be found in COVID‐19 pneumonia, even with no risk factors nor mechanical ventilation administration.

Pneumothorax reflects the presence of air in the pleural cavity. 1 Tension pneumothorax is a serious condition in which the trapped air causes shifting of the mediastinum as a result of the high pressure in the pleural space. 1 It is seen in approximately 1-2 percent of pneumothorax cases with a higher rate in patients with trauma and patients receiving mechanical ventilation. 2 Although chest x-ray is usually the initial investigation for pneumothorax, chest computed tomography scan (CT) is the best modality, especially in complicated cases, in which it can determine the presence, size, and location of intrapleural gas. 3 Bronchopleural fistula (BPF) is a sinus tract between a bronchus and the pleural cavity. 4 It usually presents as a complication of pneumonectomy or surgery on the lung; however, many other causes have been described including pneumonia with necrosis, chest radiation, invasive malignancy, and tuberculosis. 4 Treatment for BPF can be medical, bronchoscopic, or surgical depending on the clinical condition and the underlying cause. 4 Bronchopleural fistula can cause significant morbidity and mortality mainly due to aspiration pneumonia or tension pneumothorax. 4

A 40-year-old non-smoker, previously healthy gentleman, presented with worsening shortness of breath and sore throat for a few days. A chest x-ray showed bilateral airspace patchy opacities suggestive of pneumonia ( Figure 1A ). Polymerase Chain Reaction (PCR) from a nasopharyngeal swab was positive for SARS-CoV-2. On admission, the patient was afebrile, but tachypneic and required continuous positive airway pressure therapy (CPAP) alternating with 50 liters of high flow nasal canula of oxygen to maintain his oxygen saturation around 92%. The patient was admitted into the intensive care unit as a case of severe COVID-19 pneumonia. He was treated according to the local COVID-19 protocol including methylprednisolone, remidisivir, azithromycin, tocilizumab, and intravenous immunoglobulin. The patient did not require intubation nor central line insertion during hospitalization.

Three weeks after admission, the patient was suffering from rapid worsening of shortness of breath, using accessory respiratory muscles, and required higher levels of oxygen. Chest X-ray showed right-sided tension pneumothorax with collapsed right lung and pushed heart and mediastinum to the left side ( Figure 1B) . A Figure 1C ). Chest CT scan showed bilateral diffuse ground-glass opacities, moderate right-sided pneumothorax, minimal right-sided pleural effusion, and right chest tube seen in situ ( Figure 1D ). However, it did not show any underlying emphysema or bullae. Over the next few days, the chest tube was kept in place to give time for healing. However, it was continuously bubbling for the next 3 weeks. Gathering the above findings, the picture suggested that a bronchopleural fistula is the reason behind the persistent air leak. Given the unstable lungs' condition, the patient was not fit for a surgical intervention at that point. Therefore, the decision was to keep the chest tube as long as possible or to discharge him with Hemlich valve waiting for spontaneous recovery or possible surgical intervention once he is medically fit.

The chest tube was incidentally removed on day 42 post-insertion, then the pneumothorax reaccumulated while the patient clinically remained stable (Figure 2A) . A right intercostal pigtail catheter was inserted in the 2nd intercostal space into the mid-clavicular line. On day 52 post chest tube insertion (10 days later), the chest tube had showed no more bubbling for 2 days, so the pigtail catheter was removed. The patient was discharged after 3 days of observation ( Figure 2B) . The patient had a follow-up phone call after 1 week which demonstrated no active complaints.

Recent studies on COVID-19 patients showed a pneumothorax prevalence of 1-2%, 2,5 with higher incidence among patients on mechanical ventilation compared to those who are not. 6 However, bronchopleural fistula is extremely rare in previously fit patients with no complicated hospital course such as mechanical ventilation requirement or superinfection. Although there are a few reported cases of tension pneumothorax among COVID-19 pneumonia patients, bronchopleural fistula in relation to COVID-19 pneumonia has been reported only in very few ones. 7, 8 Also, these reported cases were of patients with accompanied issues such as necrotic fungal co-infection 9 and long-term mechanical ventilation. 8, 10 We think that patients with no comorbidities nor complicated hospital course might be overlooked for as such a rare complication as bronchopleural fistula. Our patient was middle aged, had no comorbidities, non-smoker, required only continuous positive airway pressure therapy (CPAP) for a short duration, and his CT chest showed signs of pneumonitis with no evidence of lung necrosis. These findings subsequently suggest that the bronchopleural fistula is solely due to COVID-19 pneumonia. So, BPF should be kept in mind in cases of sudden persistent deterioration of COVID-19 pneumonia patients, even with absence of apparent risk factors, and even in patients who have not been placed on mechanical ventilation.

Additionally, our patient was successfully treated conservatively with prolonged chest tube drainage (53 days), which indicates that surgical or more invasive treatment is not always required. On the contrary, the related cases in the literature were treated invasively with, for instance, salvage lobectomy, 7 and Endobronchial valves. 11

Sole COVID-19 pneumonia can cause bronchopleural fistula, which leads to persistent pneumothorax. Keep this possibility in mind even in patients who are not on mechanical ventilation. Also, less-invasive management with a long-term chest tube can be considered as an effective intervention especially for patients who are not candidate for surgery. 

Pneumothorax SET. StatPearls Publishing. 2021. n.d

Value of ultrasound in diagnosis of pneumothorax: a prospective study

Essential clinical anesthesia review: keywords

Coronavirus disease 2019 (COVID-19): a systematic review of imaging findings in 919 patients

Pneumothorax in critically ill patients with COVID-19 infection: incidence, clinical characteristics and outcomes in a case control multicenter study

Salvage lobectomy to treat necrotizing SARS-CoV-2 pneumonia complicated by a bronchopleural fistula

Use of endobronchial valve to treat COVID-19 adult respiratory distress syndrome-related alveolopleural fistula

Bronchopleural fistula development in the setting of novel therapies for acute respiratory distress syndrome in SARS-CoV-2 pneumonia

Pulmonary pathology of COVID-19 following 8 weeks to 4 months of severe disease: a report of three cases, including one with bilateral lung transplantation

Bronchopleural fistula as a complication in a COVID-19 patient managed with endobronchial valves

The authors would like to thank the patient for allowing us to share his details with the medical community. Additionally, we acknowledge the Qatar National Library for funding the open access fees of this publication.

The authors report no conflict of interest.

The first author (MBH) involved in conceptualization, writing-original draft. IO and KA participated in literature review and editing the manuscript. MA prepared the graphs. MM involved in revision and editing.

The clinical case and accompanying images were approved by the Medical Research Centre (MRC) in Hamad Medical Corporation (HMC), Qatar, before submission.

Written consent was taken from the patient for the brief clinical case and accompanying images before submission.

The data that support the findings of this study are available from the corresponding author upon reasonable request.